Literature DB >> 18292237

Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Laura A Maile1, Byron E Capps, Emily C Miller, Lee B Allen, Umadevi Veluvolu, Ariel W Aday, David R Clemmons.   

Abstract

Vascular smooth muscle cells (SMC) maintained in high glucose are more responsive to IGF-I than SMC maintained in normal glucose due to a difference in the Shc phosphorylation response. In this study we aimed to determine the mechanism by which glucose regulates the sensitivity of SMC to IGF-I. For Shc to be phosphorylated in response to IGF-I it must be recruited to tyrosine-phosphorylated sites on Src homology 2 domain-containing phosphatase (SHP) substrate-1 (SHPS-1). The association of integrin-associated protein (IAP) with SHPS-1 is required for SHPS-1 tyrosine phosphorylation. When SMC were grown in 5 mm glucose, the amount of intact IAP was reduced, compared with SMC grown in 25 mm glucose. This reduction was due to proteolytic cleavage of IAP. Proteolysis of IAP resulted in loss of its SHPS-1 binding site, which led to loss of SHPS-1 phosphorylation. Analysis of the conditioned medium showed that there was more protease activity in the medium from SMC cultured in 5 mm glucose as compared with 25 mm. Inhibition of matrix metalloprotease-2 synthesis using RNA interference or its activity using a specific protease inhibitor protected IAP from cleavage. This protection was associated with an increase in IAP-SHPS-1 association, increased recruitment and phosphorylation of Shc, and increased cell growth in response to IGF-I. Our results show that the enhanced response of SMC in 25 mm glucose to IGF-I is due to the protection of IAP from proteolytic degradation, thereby increasing its association with SHPS-1 and allowing the formation of the SHPS-1-Shc signaling complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292237      PMCID: PMC2366182          DOI: 10.1210/me.2007-0552

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  38 in total

Review 1.  The AMP-activated protein kinase pathway--new players upstream and downstream.

Authors:  D Grahame Hardie
Journal:  J Cell Sci       Date:  2004-11-01       Impact factor: 5.285

2.  The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.

Authors:  Laura A Maile; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

3.  The effects of high glucose and atorvastatin on endothelial cell matrix production.

Authors:  S McGinn; P Poronnik; E D M Gallery; C A Pollock
Journal:  Diabet Med       Date:  2004-10       Impact factor: 4.359

4.  Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.

Authors:  Malcolm Campbell; William E Allen; Carol Sawyer; Bart Vanhaesebroeck; Elisabeth R Trimble
Journal:  Circ Res       Date:  2004-07-08       Impact factor: 17.367

5.  Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.

Authors:  Laura A Maile; David R Clemmons
Journal:  Circ Res       Date:  2003-10-16       Impact factor: 17.367

6.  Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.

Authors:  A Y Strongin; I Collier; G Bannikov; B L Marmer; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

7.  Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.

Authors:  A G Gao; F P Lindberg; M B Finn; S D Blystone; E J Brown; W A Frazier
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

8.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

9.  Transendothelial migration of neutrophils involves integrin-associated protein (CD47).

Authors:  D Cooper; F P Lindberg; J R Gamble; E J Brown; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

View more
  17 in total

1.  An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.

Authors:  Laura A Maile; Victoria E DeMambro; Christine Wai; Sutada Lotinun; Ariel W Aday; Byron E Capps; Wesley G Beamer; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

2.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

3.  Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.

Authors:  Sukhbir Kaur; Svetlana A Kuznetsova; Michael L Pendrak; John M Sipes; Martin J Romeo; Zhuqing Li; Lijuan Zhang; David D Roberts
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

4.  Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Walker H Busby; Xinchun Shen; Laura A Maile; David R Clemmons
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes.

Authors:  L A Maile; K Gollahon; C Wai; G Byfield; M E Hartnett; D Clemmons
Journal:  Diabetologia       Date:  2011-12-23       Impact factor: 10.122

6.  IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Xinchun Shen; Laura A Maile; Gang Xi; David R Clemmons
Journal:  Mol Endocrinol       Date:  2011-07-28

Review 7.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

8.  Identification of compounds that inhibit IGF-I signaling in hyperglycemia.

Authors:  Laura A Maile; Lee B Allen; Umadevi Veluvolu; Byron E Capps; Walker H Busby; Michael Rowland; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-01-06

9.  Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation.

Authors:  Laura A Maile; Lee B Allen; Christopher F Hanzaker; Katherine A Gollahon; Paul Dunbar; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-06-20

Review 10.  Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.

Authors:  David R Soto-Pantoja; Erica V Stein; Natasha M Rogers; Maryam Sharifi-Sanjani; Jeffrey S Isenberg; David D Roberts
Journal:  Expert Opin Ther Targets       Date:  2012-10-27       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.